Intellectual Property India Publishes Patent Application for 'Ccr2 Inhibitors And Methods Of Use' Filed by Orion Biotechnology USA Corp.

MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202517049935 A) filed by Orion Biotechnology USA Corp., Wilmington, U.S.A., on May 23, for 'ccr2 inhibitors and methods of use.'

Inventor(s) include Hartley, Oliver; Rossitto-Borlat, Irene; Cerini, Fabrice; Calo, Nicolas; Lani, Rachid; Goncalves Martins, Elsa; Mothukuri, Ganesh Kumar; and Paolini-Bertrand, Marianne.

The application for the patent was published on Aug. 1, under issue no. 31/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to CCR2 inhibitors that are variant CCL2 polypeptides comprising a variant N-terminal portion and a conserved C-terminal portion, and peptides and uses thereof."

The patent application was internationally filed on Oct. 31, 2023, under International application No.PCT/EP2023/080341.

Disclaimer: Curated by HT Syndication.